ABOUT LINK ALTERNATIF MBL77

Not all individuals with CLL call for therapy. Regardless of all the latest advances, the iwCLL even now endorses watchful observation for sufferers with asymptomatic illness.86 This advice is predicated on at least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,